Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment

Objective: To assess the role of social risk factors on adherence to tyrosine kinase inhibitors (TKI) therapy in chronic myeloid leukemia (CML) patients. Methods: This is a retrospective study and eligible patients were adults with CML on TKI treatment. Cases of no adherence to treatment were confir...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacy Practice
Principais autores: Lucas M. OKUMURA, Valquíria D. ANTUNES, Karina S. AGUIAR, Tatiane FARIAS, Vânia M. ANDRZEJEVSKI, Vaneuza M. FUNKE
Formato: Artigo
Idioma:Inglês
Publicado em: Centro de investigaciones y Publicaciones Farmacéuticas 2015
Assuntos:
Medicina
Brazil
Myeloid
Leukemia
Risk Factors
Medication Adherence
Acesso em linha:https://www.redalyc.org/articulo.oa?id=69041178007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados